Hamilton, Canada

Dimitri Denisov

This inventor holds 1 USPTO granted patent. Top assignee: Tel Aviv University. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dimitri Denisov. Retrieved from https://idiyas.com/inventor/dimitri-denisov-cwzotzm4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Dimitri Denisov

Introduction

Dimitri Denisov is a notable inventor based in Hamilton, Canada. He has made significant contributions to the field of biotechnology, particularly in the area of mapping and reconstituting binding surfaces for monoclonal antibodies.

Latest Patents

Denisov holds a patent titled "Mapping and reconstitution of a conformational discontinuous binding surface." This patent focuses on the structure of conformational, discontinuous binding surfaces that associate with binding molecules, specifically the epitopes of monoclonal antibodies (mAbs). The invention allows for the selection of specific peptides from a peptide library, which are then used to create a binding surface database. A novel computer algorithm analyzes the crystalline structure of the original binding surface, enabling the reconstitution of antigenic epitope-mimetics recognized by their original mAbs. This work has implications for developing vaccines aimed at preventing or treating HIV.

Career Highlights

Denisov is affiliated with Ramot at Tel Aviv University Ltd., where he continues to advance his research and innovations. His work has garnered attention for its potential applications in medical science and vaccine development.

Collaborations

Denisov has collaborated with notable colleagues, including Jonathan M Gershoni and Erez Moshe Bublil. Their combined expertise contributes to the advancement of research in the field.

Conclusion

Dimitri Denisov's innovative work in mapping binding surfaces for monoclonal antibodies represents a significant advancement in biotechnology. His contributions have the potential to impact vaccine development and improve therapeutic strategies against diseases like HIV.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…